AVIR
Atea·NASDAQ
--
--(--)
--
--(--)
AVIR Filings
Filing Date
Form Description
Form Type
2026-02-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-08
Form 8-K - Current report
Key Events
2026-01-08 · Key Events
Form 8-K - Current report
2025-12-05
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-05 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12
Atea Pharmaceuticals, Inc. (AVIR) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-12 · Earnings Call
Atea Pharmaceuticals, Inc. (AVIR) Q3 2025 Earnings Call Transcript
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
